Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients
Natural history of superficial bladder tumors: 10- to 20-year follow-up of treated patients
复制标题
DOI：
10.1007/bf02201977
复制
发表时间：
1997-04-01
影响因子：
3.4
通讯作者：
Herr, HW
中科院分区：
文献类型：
--
作者：
Herr, HW
浅表性膀胱肿瘤（Ta、T1、Tis）占原发性膀胱癌的 80%。经尿道切除和膀胱内治疗可成功控制大多数此类肿瘤长达 5 年。然而，患有多发性或复发性 Ta、T1 和 Tis 膀胱癌的患者终生有发生分期进展和上尿路肿瘤的风险。一半的人有最终接受膀胱切除术的风险，三分之一的人有在 15-20 年内死于膀胱癌的风险。
Superficial bladder tumors (Ta, T1, Tis) account for 80% of primary bladder cancers. Transurethral resection and intravesical therapy are successful in controlling the majority of these tumors for up to 5 years. However, patients with multiple or recurrent Ta, T1 and Tis bladder cancer have a lifelong risk of developing stage progression and upper tract tumors. One-half are at risk of having cystectomy eventually and one-third are at risk over a 15-20 year period of dying of bladder cancer.